Sepsis and Organ Dysfunction

Epidemiology and Scoring Systems Pathophysiology and Therapy
Herausgegeben:Baue, A. E.; Berlot, G.; Gullo, A.

• Broschiertes Buch

Produktbeschreibung

Sepsis is a syndrome or sometimes it is a clinical condition evoked by uncontrolled endotoxin-reactions. These pathophysiological alterations can disturb the organism's homeostasis leading ultimately to a condition of severe organ dysfunction which in itself means a bad prognosis for patient survival. In the last decades researchers and clinicians have been involved in process directed to a better understanding of the basic mechanisms of sepsis and MODS. The best goal will be the achievement of preventive measures and optimization of management in patients suffering severe infections and critical conditions. This objective represents a true challenge at the dawn of the XXI century.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Springer / Springer Milan / Springer, Berlin
• Artikelnr. des Verlages: 978-88-470-0297-5
• 1997.
• Seitenzahl: 196
• Erscheinungstermin: 1. November 1997
• Englisch
• Abmessung: 244mm x 170mm x 11mm
• Gewicht: 360g
• ISBN-13: 9788847002975
• ISBN-10: 8847002974
• Artikelnr.: 25534847

Inhaltsangabe

Epidemiology and Clinical Course of Sepsis and MODS.- Epidemiology and Clinical Course of Sepsis.- The Complexities of Sepsis and Organ Dysfunction.- Scoring Systems.- An Overview to Introduce Prognostic Indexes in MODS.- Multiple Organ Dysfunction (MOD) Score.- The Logistic Organ Dysfunction (LOD) System.- Will the Use of Scores Benefit the Individual Patient and Improve Therapy?.- Mediators and Prostaglandins.- Old and New Mediators in Sepsis. The Enigma Is Not Yet Resolved.- Modulating Prostaglandin Metabolism in Sepsis.- DO2/VO2 In Sepsis.- Oxygen Delivery and Consumption Relationships in Sepsis The Role of Inotropic and Vasoactive Drugs.- Coagulation.- Disturbances and Modulators of Coagulation and Fibrinolysis in Sepsis.- Experimental and Clinical Approach.- Therapies Directed against TNF-? and IL-1 during Sepsis.- Effects of Adrenergic Agents on the Hepato-Splanchnic Circulation: An Update.- When to Operate or to Stop Operating and to Plan a Reoperation.- Multiple Therapeutic Agents-Are We Making Progress?.- Neuromuscular Dysfunction.- SIRS and Sepsis-Induced Neuromuscular Dysfunctions.- Prevention and Management of Sepsis and MODS.- Lights and Shadows in Sepsis and Multiple Organ Dysfunction Syndrome (MODS).